NeurAxis Inc Sustainability Reports
Neuraxis, Inc. is a medical technology company that develops neuromodulation therapies to address chronic and debilitating conditions. Its primary focus is on treating disorders of gut-brain interaction, such as functional abdominal pain associated with irritable bowel syndrome, using drug-free and non-surgical device technology.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
FIGI: BBG01C9N1368
2 reports from 2023 to 2024
Company Profile
Neuraxis, Inc. is a medical technology company that develops neuromodulation therapies to address chronic and debilitating conditions. Its primary focus is on treating disorders of gut-brain interaction, such as functional abdominal pain associated with irritable bowel syndrome, using drug-free and non-surgical device technology.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
